Publications by authors named "Daniel Geh"

Claim this Profile
I
Improving surgical treatments for hepatocellular carcinoma.
Abdullah K Malik, Daniel Geh, Thomas R Jeffry Evans, Pierce K H Chow, Derek A Mann

Nat Rev Gastroenterol Hepatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision-cut tumor slices for modeling hepatocellular carcinoma enable at-scale drug screening.
Amy L Collins, Keara Kirkness, Erik Ramon-Gil, Eleni Tzortzopoulou, Daniel Geh

Hepatol Commun· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer.
Rebecca Garnham, Daniel Geh, Ryan Nelson, Erik Ramon-Gil, Laura Wilson

Commun Biol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
c-Rel-dependent Chk2 signaling regulates the DNA damage response limiting hepatocarcinogenesis.
Jack Leslie, Jill E Hunter, Amy Collins, Amelia Rushton, Lauren G Russell, Daniel Geh

Hepatology· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing neutrophil plasticity for HCC immunotherapy.
Erik Ramon-Gil, Daniel Geh, Jack Leslie

Essays Biochem· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of COVID-19 on 1-Year Survival Outcomes in Hepatocellular Carcinoma: A Multicenter Cohort Study.
Shuell De Souza, Jeffrey Kahol de Jong, Ylenia Perone, Shishir Shetty, Maria Qurashi, Daniel Geh

Cancers (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sulfatase-2 from Cancer Associated Fibroblasts: An Environmental Target for Hepatocellular Carcinoma?
Marco Y W Zaki, Sari F Alhasan, Ruchi Shukla, Misti McCain, Maja Laszczewska, Daniel Geh

Liver Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic dysfunction and cancer in HCV: Shared pathways and mutual interactions.
Jack Leslie, Daniel Geh, Ahmed M Elsharkawy, Derek A Mann, Michele Vacca

J Hepatol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophils as potential therapeutic targets in hepatocellular carcinoma.
Daniel Geh, Jack Leslie, Rob Rumney, Helen L Reeves, Thomas G Bird

Nat Rev Gastroenterol Hepatol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 and liver cancer: lost patients and larger tumours.
Daniel Geh, Robyn Watson, Gourab Sen, Jeremy J French, John Hammond

BMJ Open Gastroenterol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCR2 inhibition enables NASH-HCC immunotherapy.
Jack Leslie, John B G Mackey, Thomas Jamieson, Erik Ramon-Gil, Thomas M Drake, Daniel Geh

Gut· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulatory Effects of Lenvatinib Plus Anti-Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma.
Laura Torrens, Carla Montironi, Marc Puigvehí, Agavni Mesropian, Jack Leslie, Daniel Geh

Hepatology· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Latent Cytomegalovirus Infection and Previous Capsular Polysaccharide Vaccination Predict Poor Vaccine Responses in Older Adults, Independent of Chronic Kidney Disease.
Nadezhda Wall, Alexandra Godlee, Daniel Geh, Charlotte Jones, Sian Faustini

Clin Infect Dis· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophils induce paracrine telomere dysfunction and senescence in ROS-dependent manner.
Anthony Lagnado, Jack Leslie, Marie-Helene Ruchaud-Sparagano, Stella Victorelli, Petra Hirsova, Daniel Geh

EMBO J· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NAFLD-Associated HCC: Progress and Opportunities.
Daniel Geh, Quentin M Anstee, Helen L Reeves

J Hepatocell Carcinoma· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocellular carcinoma in non-alcoholic fatty liver disease-a review of an emerging challenge facing clinicians.
Daniel Geh, Derek M Manas, Helen L Reeves

Hepatobiliary Surg Nutr· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weighing the benefits of hepatocellular carcinoma surveillance against potential harms.
Daniel Geh, Fahd A Rana, Helen L Reeves

J Hepatocell Carcinoma· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epratuzumab for the treatment of systemic lupus erythematosus.
Daniel Geh, Caroline Gordon

Expert Rev Clin Immunol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biliary epithelium and liver B cells exposed to bacteria activate intrahepatic MAIT cells through MR1.
Hannah C Jeffery, Bonnie van Wilgenburg, Ayako Kurioka, Krishan Parekh, Kathryn Stirling, Daniel Geh

J Hepatol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac magnetic resonance imaging: a tool to diagnose parasitic infection?
Alexander Loch, Daniel Joseph Geh, Ramesh Singh Veriah

Eur Heart J· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis